AstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips
The Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side effects such as blood clots and low blood platelet counts.
AstraZeneca (AZN.L) said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorisations within Europe.
Related Stories
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
According to the media, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side effects such as blood clots and low blood platelet counts.
The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.
The admission came after the company was slapped with a class action lawsuit in the UK which claimed that the vaccine had caused deaths and severe injuries and sought damages up to £100m for about 50 victims.
“It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known,” AstraZeneca said in court documents in February, the newspaper reported.
TTS is Thrombosis with Thrombocytopenia Syndrome, which is characterised by blood clots and low blood platelet counts in humans.
AstraZeneca’s vaccine was developed in collaboration with Oxford University and produced by the Serum Institute of India. It was widely administered in over 150 countries, including Britain and India.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
Top Topics This Week
Dawoodi Bohras
Syedna Mufaddal Saifuddin
Bohra community
Rafah
rafah airstrikes
rafah conflict
israel attacks rafah
rafah invasion
israel operation in rafah
rafah attacks
DR Congo
DRC conflict
President Felix Tshisekedi
DRC army
DRC soldier killed
DRC violence
DRC rebels
DRC President Felix Tshisekedi
DRC attacks
Pharmacy and Poisons Board
Trending
EGYPT-UN-PALESTINIAN-ISRAEL-CONFLICT-BORDER-AID
Dennis Tarus
|
6 months ago
Thousands of Dawoodi Bohras gather in Mombasa for week-long spiritual celebrations
Lucy Mumbi
|
10 hours ago
Learners affected by floods to be admitted to neighbouring schools -Ministry
Bashir Mohammed
|
1 day ago
Garissa residents start to rebuild after floods
Issa Hussein
|
7 hours ago